Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycine in Schizophrenia and Co-morbid Alcoholism
NCT00338598Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2003
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycine in schizophrenia, alcohol use disorder (AUD), sponsored by Yale University. Started Jun 2003; status: completed.
02
Drugs
glycine
03
Conditions
schizophreniaalcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00338598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338598.